The different effects of endocrine-disrupting chemicals on estrogen receptor-mediated transcription through interaction with coactivator TRAP220 in uterine tissue

Journal of Molecular Endocrinology

Volumn 31, Issue 3, 2003, Pages 551-561

  Inoshita, H ^a   Masuyama, H ^a,b   Hiramatsu, Y ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ALCOHOL; ANDROGEN RECEPTOR; CELL NUCLEUS RECEPTOR; CHLORPHENOTANE; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR BETA; MEMBRANE RECEPTOR; NUCLEAR PROTEIN; PHTHALIC ACID; PROTEIN TRAP220; THYROID HORMONE RECEPTOR ASSOCIATED PROTEIN 220; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOCRINE FUNCTION; ESTROGEN ACTIVITY; FEMALE; GENETIC TRANSCRIPTION; HORMONE RECEPTOR INTERACTION; HORMONE SYNTHESIS; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RECEPTOR BINDING; STEROIDOGENESIS; UTERUS;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; ENDOMETRIUM; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; MICE; PHENOLS; PHTHALIC ACIDS; PROTEIN BINDING; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 0347359055     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0310551     Document Type: Article

References (22)

1. Brozozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson J-A & Carlquist M 1997 Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389 753-758.
2. Burakov D, Wong CW, Ranchez C, Cheskis BJ & Freedman LP 2000 Functional interactions between the estrogen receptor and DRIP205, a subunit ofthe heretomeric DRIP coactivator complex. Journal of Biological Chemistry 275 20928-20934.
3. Cooper RL &- Kavlock RJ 1997 Endocrine disrupters and reproductive development: a weight-of-evidence overview. Journal of Endocrinology 152 159-166.
4. Durfee T, Becherer K, Chen P-L, Yeh S-H, Yang Y, Kilburn AE, Lee W-H & Elledge SJ 1993 The retinoblastoma protein associates with the protein phosphatase type I catalytic subunit. Genes and Development 7 555-569.
5. Evans RM 1988 The steroid and thyroid hormone receptor Superfamily. Science 240 889-895.
6. Freedman LP 1997 Increasing the complexity of coactivation in nuclear receptor signaling. Cell 97 5-8.
7. Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS & Tung L 1996 Nuclear receptor coactivators and corepressors. Molecular Endocrinology 10 1167-1177.
8. Kang YK. Guermah M, Yuan CX & Roeder RG 2002 The IRAP/mediator coactivator complex interacts directly with estrogen receptors α and β through the TRAP220 subunit and directly enhances estrogen function in vitro. PNAS 99 2642-2647.
9. Kavlock RJ, Daston GP, DeRosa C, Fenner-Crisp P, Gray LE, Moore J, Rolland R, Scott G, Sheehan DM, Sinks T el al. 1996 A report of the US EPA-sponsored workshop. Environmental Health Perspectives 104 715-740.
10. Kuiper GGJM, Lemmen JG, Carlsson BO, Corton JC, Safe SH, Saag PT, Burg B & Gustafsson J-A 1998 Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139 4252-4263.
11. Mangelsdorf DJ & Evans RM 1995 The RXR heterodimers and orphan receptors. Cell 83 841-850.
12. Masuyama H & MacDonald PN 1998 Proteasome-mediated degradation of the vitamin D receptor (VDR) and a putative role for SUG1 interaction with the Af-2 domain of VDR. Journal of Cellular Biochemistry 71 429-440.
13. Masuyama H, Jefcoat SC & MacDonald PN 1997a The N-terminal domain of transcription factor IIB is required for direct interaction with vitamin D receptor and participates in vitamin D-mediated transcription. Molecular Endocrinology 11 218-228.
14. Masuyama H, Brownfield C, St-Arnaud R & MacDonald P 1997b Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. Molecular Endocrinology 11 1507-1517.
15. Masuyama H, Hiramatsu Y, Kunitomi M, Kudo T & MacDonald PN 2000 Endocrine disrupting chemicals phthalic acid and nonylphenol activate pregnane X receptor-mediated transcription. Molecular Endocrinology 14 421-428.
16. Masuyama H, Inoshita H, Hiramatsu Y & Kudo T 2002 Ligands have various potential effects on the degradation of pregnane X receptor by proteasome. Endocrinology 143 55-61.
17. McKenna NJ & O'Malley BW 2002 Combinatorial control of gene pression by nuclear receptors and coregulator. Cell 108 465-474.
18. McKenna NJ, Lanz RB & O'Malley BW 1999 Nuclear receptor coregulators: cellular and molecular biology. Endocrine Reviews 20 321-344.
19. Rachez C, Gamble M, Chang CB, Atkins GB, Lazar MA & Freedman LP 2000 The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes. Molecular and Cellular Biology 20 2718-2726.
20. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA & Greene GL 1998 The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95 927-937.
21. Tsai MJ & O'Malley BW 1994 Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annual Review of Biochemistry 63 451-486.
22. Warnmark A, Almlof T, Leers J, Gustafsson J-A & Treuter E 2001 Different recruitment of the mammalian mediator subunit TRAP220 by estrogen receptors ERα and ERβ. Journal of Biological Chemistry 276 23397-23404.